Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Pandemic Effect of COVID-19: Identification, Present Scenario, and Preventive Measures Using Machine Learning Model Read chapter Read first chapter

2023 | OriginalPaper | Chapter

Effective Health Screening and Prompt Vaccination to Counter the Spread of COVID-19 and Minimize Its Adverse Effects

Authors : Sandip Bag, Swati Sikdar

Published in: System Design for Epidemics Using Machine Learning and Deep Learning

Publisher: Springer International Publishing

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Precautionary measures are the best conceivable ways to impede the spreading of COVID-19 disease. Initial stage detection, proper analysis, suitable confinement, effective therapy and prompt vaccination are the key consideration to inhibit expedite transmission. Precautions are primarily concentrated on effective health screening, efficient treatment, and vaccination on time for each and every individual. Before the invention of COVID-19 vaccine, proper health checking or explorations are of predominant concern from therapeutic viewpoint as avoidance is superior than healing. At present scenario, impressive health screening through RT-PCR test, rapid antigen test, etc. is very imperative to identify Corona-positive cases in early stages even there is no disorders or symptoms of COVID-19 infection. Faster vaccination of most of the people, irrespective of cast, religion, and economic conditions, is indispensable to prohibit the transportation of such growing disorder and minimize its adverse effects. Recent literature reveals that most of the vaccines are safe and effective against coronavirus. A potent and competent vaccine lessens mild to moderate and serious conditions of COVID-19 patients regardless of comorbidities.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

inform now
previous chapter Advances and Application of Artificial Intelligence and Machine Learning in the Field of Cardiovascular Diseases and Its Role During the Pandemic Condition
next chapter Crowd Density Estimation Using Neural Network for COVID-19 and Future Pandemics
Literature
1.
S. Bag, S. Sikdar, K. Ganguly, S. Banerjee, P. Lahiri, Effective health screening to prevent infection and control the spreading of COVID-19. J. Phys. Conf. Ser. 1797(1), 012040 (2021)CrossRef
2.
H. Zhu, L. Wei, P. Niu, The novel coronavirus outbreak in Wuhan, China. Glob. Health Res. Policy 5, 6 (2020)CrossRef
3.
A. Sharma, S. Tiwari, M.K. Deb, J.L. Marty, Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A global pandemic and treatment strategies. Int. J. Antimicrob. Agents 56(2), 106054 (2020)CrossRef
4.
C.-C. Lai, T.-P. Shih, W.-C. Ko, H.-J. Tang, P.-R. Hsuehe, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents 55(3), 105924 (2020)CrossRef
5.
Y.-C. Wu, C.-S. Chen, Y.-J. Chan, The outbreak of COVID-19: An overview. J. Chin. Med. Assoc. 83(3), 217–220 (2020)CrossRef
6.
D. Wu, T. Wu, Q. Liu, Z. Yang, The SARS-CoV-2 outbreak: What we know. Int. J. Infect. Dis. 94, 44–48 (2020)CrossRef
7.
W. Guan, Z. Ni, Y. Hu, W. Liang, C. Ou, J. He, L. Liu, H. Shan, C. Lei, D.S.C. Hui, B. Du, L. Li, G. Zeng, K.Y. Yuen, R. Chen, C. Tang, T. Wang, P. Chen, J. Xiang, S. Li, J.-l. Wang, Z. Liang, Y. Peng, L. Wei, Y. Liu, Y.-h. Hu, P. Peng, J.-m. Wang, J. Liu, Z. Chen, G. Li, Z. Zheng, S. Qiu, J. Luo, C. Ye, S. Zhu, N. Zhong, Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020, 1708–1720 (2020)CrossRef
8.
S. Zaim, J.H. Chong, V. Sankaranarayanan, A. Harky, COVID-19 and multiorgan response. Curr. Probl. Cardiol. 45(8), 100618 (2020)CrossRef
9.
S. Mandal, T. Bhatnagar, N. Arinaminpathy, A. Agarwal, A. Chowdhury, M. Murhekar, R.R. Gangakhedkar, S. Sarkar, Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach. Indian J. Med. Res. 151(2 & 3), 190–199 (2020)
10.
M. Jayaweera, H. Perera, B. Gunawardana, J. Manatungea, Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ. Res. 188, 109819 (2020)CrossRef
11.
S. Sanche, Y.T. Lin, C. Xu, E. Romero-Severson, N. Hengartner, R. Ke, High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg. Infect. Dis. 26, 1470–1477 (2020)CrossRef
12.
W.E. Wei, Z. Li, C.J. Chiew, S.E. Yong, M.P. Toh, V.J. Lee, Singapore presymptomatic transmission of SARS-CoV-2. MMWR Morb. Mortal. Wkly Rep. 69, 411–415 (2020)CrossRef
13.
J. Chen, Pathogenicity and transmissibility of 2019-nCoV – a quick overview and comparison with other emerging viruses. Microbes Infect. 22, 69–71 (2020)CrossRef
14.
R. Guner, İ. Hasanoğlu, F. Aktas, COVID-19: prevention and control measures in community. Turk. J. Med. Sci. 50(SI-1), 571–577 (2020)CrossRef
15.
M. Lotfi, M.R. Hamblin, N. Rezaei, COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin. Chim. Acta 508, 254–266 (2020)CrossRef
16.
R. Keni, A. Alexander, P.G. Nayak, J. Mudgal, K. Nandakumar, COVID-19: emergence, spread, possible treatments, and global burden. Front. Public Health 8, 216 (2020)CrossRef
17.
F. Krammer, SARS-CoV-2 vaccines in development. Nature 586, 516–527 (2020)CrossRef
18.
J.P. Moore, P.A. Offit, SARS-CoV-2 vaccines and the growing threat of viral variants. JAMA 325(9), 821–822 (2021)CrossRef
19.
J.M.G. Wilson, G. Jungner, Principles and Practice of Screening for Disease, Public Health Papers Number 34 (Geneva, WHO, 1968)
20.
L.D. Maxim, R. Niebo, M.J. Utell, Screening tests: a review with examples. Inhal. Toxicol. 26(13), 811–828 (2014)CrossRef
21.
A.N. Desai, P. Patel, Stopping the spread of COVID-19. JAMA 323, 1516 (2020)CrossRef
22.
B. Nussbaumer-Streit, V. Mayr, A.I. Dobrescu, A. Chapman, E. Persad, Quarantine alone or in combination with other public health measures to control COVID-19: A rapid review. Cochrane Database Syst. Rev. 4(4), CD013574 (2020)
23.
S.H.S. Tali, J.J. LeBlanc, Z. Sadiq, O.D. Oyewunmi, C. Camargo, B. Nikpour, N. Armanfard, S.M. Sagan, S. Jahanshahi-Anbuhi, Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin. Microbiol. Rev. 34(3), e00228-20 (2021)CrossRef
24.
R.S. Burnham, R.S. McKinley, D.D. Vincent, Three types of skin-surface thermometers: a comparison of reliability, validity, and responsiveness. Am. J. Phys. Med. Rehabil. 85(7), 553–558 (2006)CrossRef
25.
G.B. Dell’Isola, E. Cosentini, L. Canale, G. Ficco, M. Dell’Isola, Noncontact body temperature measurement: uncertainty evaluation and screening decision rule to prevent the spread of COVID-19. Sensors 21, 346 (2021)CrossRef
26.
P. Ghassemi, T. Joshua Pfefer, J.P. Casamento, R. Simpson, Q. Wang, Best practices for standardized performance testing of infrared thermographs intended for fever screening. PLOS ONE 13, e0203302 (2018)CrossRef
27.
R. Wölfel, V.M. Corman, W. Guggemos, M. Seilmaier, S. Zange, M.A. Müller, D. Niemeyer, T.C. Jones, P. Vollmar, C. Rothe, M. Hoelscher, T. Bleicker, S. Brünink, J. Schneider, R. Ehmann, K. Zwirglmaier, C. Drosten, C. Wendtner, Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465–469 (2020)CrossRef
28.
B.D. Kevadiya, J. Machhi, J. Herskovitz, M.D. Oleynikov, W.R. Blomberg, N. Bajwa, D. Soni, S. Das, M. Hasan, M. Patel, A.M. Senan, S. Gorantla, J.E. McMillan, B. Edagwa, R. Eisenberg, C.B. Gurumurthy, S.P.M. Reid, C. Punyadeera, L. Chang, H.E. Gendelman, Diagnostics for SARS-CoV-2 infections. Nat. Mater. 20, 593–605 (2021)CrossRef
29.
W. Joost Wiersinga, A. Rhodes, A.C. Cheng, S.J. Peacock, H.C. Prescott, Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA 324(8), 782–793 (2020)CrossRef
30.
K.C. Coffey, D.J. Diekema, D.J. Morgan, Interpreting SARS-CoV-2 test results. JAMA 326(15), 1528–1529 (2021)CrossRef
31.
B. Udugama, P. Kadhiresan, H.N. Kozlowski, A. Malekjahani, M. Osborne, V.Y.C. Li, H. Chen, S. Mubareka, J.B. Gubbay, W.C.W. Chan, Diagnosing COVID-19: the disease and tools for detection. ACS Nano 14(4), 3822–3835 (2020)CrossRef
32.
L.E. Brümmer, S. Katzenschlager, M. Gaeddert, C. Erdmann, S. Schmitz, M. Bota, M. Grilli, J. Larmann, M.A. Weigand, N.R. Pollock, A. Macé, S. Carmona, S. Ongarello, J.A. Sacks, C.M. Denkinger, Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis. PLOS Med. 18(10), e1003825 (2021)CrossRef
33.
A.E. Fiore, C.B. Bridges, N.J. Cox, “Seasonal influenza vaccines”. Vaccines for pandemic influenza. Curr. Top. Microbiol. Immunol. 333, 43–82 (2009)
34.
K.M. Edwards, W.A. Orenstein, COVID-19: Vaccines (UpToDate – Literature Review Current Through, 2022)
35.
36.
37.
M.K. Andrew, J.E. McElhaney, Age and frailty in COVID-19 vaccine development. Lancet 396(10267), 1942–1944 (2020)CrossRef
38.
G. Dagotto, J. Yu, D.H. Barouch, Approaches and challenges in SARS-CoV-2 vaccine development. Cell Host Microbe 28(3), 364–370 (2020)CrossRef
39.
S. Jain, H. Batra, P. Yadav, S. Chand, COVID-19 vaccines currently under preclinical and clinical studies, and associated antiviral immune response. Vaccine 8(4), 649 (2020)CrossRef
40.
N. Pardi, M.J. Hogan, F.W. Porter, D. Weissman, mRNA vaccines—a new era in vaccinology. Nat. Rev. Drug Discov. 17(4), 261–279 (2018)CrossRef
41.
J. Abbasi, COVID-19 and mRNA vaccines—first large test for a new approach. JAMA 324(12), 1125–1127 (2020)CrossRef
42.
B. Pulendran, P.S. Arunachalam, D.T. O’Hagan, Emerging concepts in the science of vaccine adjuvants. Nat. Rev. Drug Discov. 20, 454–475 (2021)CrossRef
43.
S.P. Kaur, V. Gupta, COVID-19 vaccine: a comprehensive status report. Virus Res. 288, 198114 (2020)CrossRef
44.
45.
T. Ura, K. Okuda, M. Shimada, Developments in viral vector-based vaccines. Vaccines (Basel) 2(3), 624–641 (2014)CrossRef
46.
Y. Lazebnik, Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects. Oncotarget 12(25), 2476–2488 (2021)CrossRef
47.
Z. Matić, M. Šantak, Current view on novel vaccine technologies to combat human infectious diseases. Appl. Microbiol. Biotechnol. 106, 25–56 (2022)CrossRef
48.
A. Jara, E.A. Undurraga, C. González, F. Paredes, T. Fontecilla, G. Jara, A. Pizarro, J. Acevedo, K. Leo, F. Leon, C. Sans, P. Leighton, P. Suárez, H. García-Escorza, R. Araos, Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N. Engl. J. Med. 385, 875 (2021)CrossRef
49.
N. Al Kaabi, Y. Zhang, S. Xia, Y. Yang, M.M. Al Qahtani, N. Abdulrazzaq, M. Al Nusair, M. Hassany, J.S. Jawad, J. Abdalla, S.E. Hussein, S.K. Al Mazrouei, M. Al Karam, X. Li, X. Yang, W. Wang, B. Lai, W. Chen, S. Huang, Q. Wang, T. Yang, Y. Liu, R. Ma, Z.M. Hussain, T. Khan, M.S. Fasihuddin, W. You, Z. Xie, Y. Zhao, Z. Jiang, G. Zhao, Y. Zhang, S. Mahmoud, I. ElTantawy, P. Xiao, A. Koshy, W.A. Zaher, H. Wang, K. Duan, A. Pan, X. Yang, Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. JAMA 326, 35 (2021)CrossRef
50.
S.L. Xia, Y.T. Zhang, Y.X. Wang, H. Wang, Y.K. Yang, G.F. Gao, W.J. Tan, G.Z. Wu, M. Xu, Z.Y. Lou, W.J. Huang, W.B. Xu, B.Y. Huang, W. Wang, W. Zhang, N. Li, Z.Q. Xie, X. Zhu, L. Ding, W.Y. You, Y.X. Zhao, J. Zhao, L.L. Huang, X.Z. Shi, Y.L. Yang, G.X. Xu, W.L. Wang, P.P. Liu, M. Ma, Y.L. Qiao, S.H. Zhao, J.J. Chai, Q.Q. Li, F. Hui, Y. Xu, X.T. Zheng, W.S. Guo, X.M. Yang, Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial. Lancet Infect. Dis. 22(2), 196–208 (2022)CrossRef
51.
M. Sadarangani, A. Marchant, T.R. Kollmann, Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat. Rev. Immunol. 21, 475–484 (2021)CrossRef
52.
M.T. Mascellino, F. Di Timoteo, M. De Angelis, A. Oliva, Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety. Infect. Drug Resist. 14, 3459–3476 (2021)CrossRef
53.
H.F. Florindo, R. Kleiner, D. Vaskovich-Koubi, R.C. Acúrcio, B. Carreira, E. Yeini, G. Tiram, Y. Liubomirski, R. Satchi-Fainaro, Immune-mediated approaches against COVID-19. Nat. Nanotechnol. 15, 630–645 (2020)CrossRef
54.
E.N. Perencevich, D.J. Diekema, M.B. Edmond, Moving personal protective equipment into the community: face shields and containment of COVID-19. JAMA 323(22), 2252–2253 (2020)CrossRef
55.
L. Martinelli, V. Kopilaš, M. Vidmar, C. Heavin, H. Machado, Z. Todorović, N. Buzas, M. Pot, B. Prainsack, S. Gajović, Face masks during the COVID-19 pandemic: a simple protection tool with many meanings. Front. Public Health 8, 606635 (2021)CrossRef
56.
T. Hasan, J. Beardsley, B.J. Marais, T.A. Nguyen, G.J. Fox, The implementation of mass-vaccination against SARS-CoV-2: a systematic review of existing strategies and guidelines. Vaccines (Basel) 9, 326 (2021)CrossRef
57.
E.J. Haas, F.J. Angulo, J.M. McLaughlin, E. Anis, S.R. Singer, F. Khan, N. Brooks, M. Smaja, G. Mircus, K. Pan, J. Southern, D.L. Swerdlow, L. Jodar, Y. Levy, S. Alroy-Preis, Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 397, 1819–1819 (2021)CrossRef
58.
A. Singanayagam, S. Hakki, J. Dunning, K.J. Madon, M.A. Crone, A. Koycheva, N. Derqui-Fernandez, J.L. Barnett, M.G. Whitfield, R. Varro, A. Charlett, R. Kundu, J. Fenn, J. Cutajar, V. Quinn, E. Conibear, P.W. Barclay, P.S. Freemont, G.P. Taylor, S. Ahmad, M. Zambon, N.M. Ferguson, P.A. Lalvani, Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet 22(2), 183–195 (2022)CrossRef
Metadata
Title
Effective Health Screening and Prompt Vaccination to Counter the Spread of COVID-19 and Minimize Its Adverse Effects
Authors
Sandip Bag
Swati Sikdar
Copyright Year
2023
Book
System Design for Epidemics Using Machine Learning and Deep Learning

Print ISBN: 978-3-031-19751-2

Electronic ISBN: 978-3-031-19752-9

Copyright Year: 2023

DOI
https://doi.org/10.1007/978-3-031-19752-9_14